| abstract |
Novel Trypanosoma cruzi antigen, known as PTc100, and a code gene, known as Tc100, coding therefor. According to the invention, Tc100 and PTc100 amino acid nucleotide sequences have been determined and described. PTc100 and Tc100 or the modified or unmodified fragments thereof, can be used directly or indirectly to detect Trypanosoma cruzi or to treat the infection caused by it in humans or animals. |